{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:53:41Z","timestamp":1792569221964,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000093","name":"U.S. Department of Health & Human Services | NIH | Center for Information Technology","doi-asserted-by":"publisher","award":["R15AI113706"],"award-info":[{"award-number":["R15AI113706"]}],"id":[{"id":"10.13039\/100000093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Zika virus (ZIKV) is a mosquito-transmitted flavivirus that has caused devastating congenital Zika syndrome (CZS), including microcephaly, congenital malformation, and fetal demise in human newborns in recent epidemics. ZIKV infection can also cause Guillain-Barr\u00e9 syndrome (GBS) and meningoencephalitis in adults. Despite intensive research in recent years, there are no approved vaccines or antiviral therapeutics against CZS and adult Zika diseases. In this report, we developed a novel live-attenuated ZIKV strain (named Z7) by inserting 50 RNA nucleotides (nt) into the 5\u2032 untranslated region (UTR) of a pre-epidemic ZIKV Cambodian strain, FSS13025. We used this particular ZIKV strain as it is attenuated in neurovirulence, immune antagonism, and mosquito infectivity compared with the American epidemic isolates. Our data demonstrate that Z7 replicates efficiently and produces high titers without causing apparent cytopathic effects (CPE) in Vero cells or losing the insert sequence, even after ten passages. Significantly, Z7 induces robust humoral and cellular immune responses that completely prevent viremia after a challenge with a high dose of an American epidemic ZIKV strain PRVABC59 infection in type I interferon (IFN) receptor A deficient (\n                    <jats:italic>Ifnar1<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    ) mice. Moreover, adoptive transfer of plasma collected from Z7 immunized mice protects\n                    <jats:italic>Ifnar1<\/jats:italic>\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice from ZIKV (strain PRVABC59) infection. These results suggest that modifying the ZIKV 5\u2032 UTR is a novel strategy to develop live-attenuated vaccine candidates for ZIKV and potentially for other flaviviruses.\n                  <\/jats:p>","DOI":"10.1038\/s41541-023-00650-w","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T01:50:55Z","timestamp":1680486655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["An effective live-attenuated Zika vaccine candidate with a modified 5\u2032 untranslated region"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8142-7342","authenticated-orcid":false,"given":"Farzana","family":"Nazneen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8098-9395","authenticated-orcid":false,"given":"E. Ashley","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3409-5484","authenticated-orcid":false,"given":"Claire","family":"Blackwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4951-2326","authenticated-orcid":false,"given":"Jonathan S.","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-7097","authenticated-orcid":false,"given":"Faqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-2475","authenticated-orcid":false,"given":"Fengwei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"650_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso, D. & Gubler Duane, J. Zika virus. Clin. Microbiol. Rev. 29, 487\u2013524 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"650_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/ana.24748","volume":"80","author":"MK White","year":"2016","unstructured":"White, M. K., Wollebo, H. S., David Beckham, J., Tyler, K. L. & Khalili, K. Zika virus: an emergent neuropathological agent. Ann. Neurol. 80, 479\u2013489 (2016).","journal-title":"Ann. Neurol."},{"key":"650_CR3","doi-asserted-by":"publisher","first-page":"e00009","DOI":"10.1128\/JVI.00009-17","volume":"91","author":"TE Morrison","year":"2017","unstructured":"Morrison, T. E. & Diamond, M. S. Animal models of Zika virus infection, pathogenesis, and immunity. J. Virol. 91, e00009\u2013e00017 (2017).","journal-title":"J. Virol."},{"key":"650_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","volume":"23","author":"MJ Gorman","year":"2018","unstructured":"Gorman, M. J. et al. An immunocompetent mouse model of Zika virus infection. Cell Host Microbe 23, 672\u2013685 e676 (2018).","journal-title":"Cell Host Microbe"},{"key":"650_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"650_CR6","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1093\/jpids\/piy120","volume":"7","author":"EL Mohr","year":"2018","unstructured":"Mohr, E. L. Modeling Zika virus-associated birth defects in nonhuman primates. J. Pediatric Infect. Dis. Soc. 7, S60\u2013S66 (2018).","journal-title":"J. Pediatric Infect. Dis. Soc."},{"key":"650_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","volume":"374","author":"J Mlakar","year":"2016","unstructured":"Mlakar, J. et al. Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951\u2013958 (2016).","journal-title":"N. Engl. J. Med."},{"key":"650_CR8","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.3389\/fmicb.2018.02028","volume":"9","author":"AM Paul","year":"2018","unstructured":"Paul, A. M. et al. Congenital Zika virus infection in immunocompetent mice causes postnatal growth impediment and neurobehavioral deficits. Front. Microbiol. 9, 2028 (2018).","journal-title":"Front. Microbiol."},{"key":"650_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jped.2018.10.016","volume":"95","author":"A Prata-Barbosa","year":"2019","unstructured":"Prata-Barbosa, A., Martins, M. M., Guastavino, A. B. & Cunha, A. Effects of Zika infection on growth. J. Pediatr. 95, 30\u201341 (2019).","journal-title":"J. Pediatr."},{"key":"650_CR10","doi-asserted-by":"publisher","first-page":"e1002203","DOI":"10.1371\/journal.pmed.1002203","volume":"14","author":"F Krauer","year":"2017","unstructured":"Krauer, F. et al. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barre syndrome: systematic review. PLoS Med. 14, e1002203 (2017).","journal-title":"PLoS Med."},{"key":"650_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/BOR.0000000000000629","volume":"31","author":"I Katz","year":"2019","unstructured":"Katz, I., Gilburd, B. & Shovman, O. Zika autoimmunity and Guillain-Barre syndrome. Curr. Opin. Rheumatol. 31, 484\u2013487 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"650_CR12","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","volume":"360","author":"MR Duffy","year":"2009","unstructured":"Duffy, M. R. et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 360, 2536\u20132543 (2009).","journal-title":"N. Engl. J. Med."},{"key":"650_CR13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3201\/eid1509.090442","volume":"15","author":"EB Hayes","year":"2009","unstructured":"Hayes, E. B. Zika virus outside Africa. Emerg. Infect. Dis. 15, 1347\u20131350 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"650_CR14","doi-asserted-by":"publisher","first-page":"e1002611","DOI":"10.1371\/journal.pmed.1002611","volume":"15","author":"MJ Counotte","year":"2018","unstructured":"Counotte, M. J. et al. Sexual transmission of Zika virus and other flaviviruses: a living systematic review. PLoS Med. 15, e1002611 (2018).","journal-title":"PLoS Med."},{"key":"650_CR15","first-page":"325","volume":"90","author":"AK Hastings","year":"2017","unstructured":"Hastings, A. K. & Fikrig, E. Zika virus and sexual transmission: a new route of transmission for mosquito-borne flaviviruses. Yale J. Biol. Med. 90, 325\u2013330 (2017).","journal-title":"Yale J. Biol. Med."},{"key":"650_CR16","doi-asserted-by":"publisher","first-page":"taaa227","DOI":"10.1093\/jtm\/taaa227","volume":"27","author":"A Wilder-Smith","year":"2020","unstructured":"Wilder-Smith, A. & Osman, S. Public health emergencies of international concern: a historic overview. J. Travel. Med. 27, taaa227 (2020).","journal-title":"J. Travel. Med."},{"key":"650_CR17","doi-asserted-by":"publisher","first-page":"S957","DOI":"10.1093\/infdis\/jix464","volume":"216","author":"KM Morabito","year":"2017","unstructured":"Morabito, K. M. & Graham, B. S. Zika virus vaccine development. J. Infect. Dis. 216, S957\u2013S963 (2017).","journal-title":"J. Infect. Dis."},{"key":"650_CR18","doi-asserted-by":"publisher","first-page":"888195","DOI":"10.3389\/fmicb.2022.888195","volume":"13","author":"PD Yadav","year":"2022","unstructured":"Yadav, P. D. et al. Zika a vector borne disease detected in newer states of India amidst the COVID-19 pandemic. Front. Microbiol. 13, 888195 (2022).","journal-title":"Front. Microbiol."},{"key":"650_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.chom.2018.05.021","volume":"24","author":"C Shan","year":"2018","unstructured":"Shan, C., Xie, X. & Shi, P. Y. Zika virus vaccine: progress and challenges. Cell Host Microbe 24, 12\u201317 (2018).","journal-title":"Cell Host Microbe"},{"key":"650_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1021\/acsinfecdis.6b00030","volume":"2","author":"C Shan","year":"2016","unstructured":"Shan, C. et al. Zika virus: diagnosis, therapeutics, and vaccine. ACS Infect. Dis. 2, 170\u2013172 (2016).","journal-title":"ACS Infect. Dis."},{"key":"650_CR21","doi-asserted-by":"crossref","unstructured":"Bai, F. & Thompson, E. A. West Nile Virus (Flaviviridae), in Encyclopedia of Virology (Fourth Edition) (eds. Bamford, D. H. & Zuckerman, M.) 884\u2013890 (Academic Press, 2021).","DOI":"10.1016\/B978-0-12-809633-8.21504-5"},{"key":"650_CR22","doi-asserted-by":"publisher","first-page":"e00459","DOI":"10.1128\/mBio.00459-19","volume":"10","author":"Y Song","year":"2019","unstructured":"Song, Y., Mugavero, J., Stauft, C. B. & Wimmer, E. Dengue and Zika virus 5\u2019 untranslated regions harbor internal ribosomal entry site functions. mBio 10, e00459\u201319 (2019).","journal-title":"mBio"},{"key":"650_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.antiviral.2008.12.007","volume":"82","author":"KG Anthony","year":"2009","unstructured":"Anthony, K. G., Bai, F., Krishnan, M. N., Fikrig, E. & Koski, R. A. Effective siRNA targeting of the 3\u2019 untranslated region of the West Nile virus genome. Antiviral Res. 82, 166\u2013168 (2009).","journal-title":"Antiviral Res."},{"key":"650_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/pathogens8040193","volume":"8","author":"F Bai","year":"2019","unstructured":"Bai, F., Thompson, E. A., Vig, P. J. S. & Leis, A. A. Current understanding of West Nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications. Pathogens 8, 193 (2019).","journal-title":"Pathogens"},{"key":"650_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.meegid.2016.05.004","volume":"43","author":"Q Ye","year":"2016","unstructured":"Ye, Q. et al. Genomic characterization and phylogenetic analysis of Zika virus circulating in the Americas. Infect. Genet. Evol. 43, 43\u201349 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"650_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/v9060137","volume":"9","author":"WC Ng","year":"2017","unstructured":"Ng, W. C., Soto-Acosta, R., Bradrick, S. S., Garcia-Blanco, M. A. & Ooi, E. E. The 5\u2019 and 3\u2019 untranslated regions of the flaviviral genome. Viruses 9, 137 (2017).","journal-title":"Viruses"},{"key":"650_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1128\/JVI.01647-08","volume":"83","author":"MF Lodeiro","year":"2009","unstructured":"Lodeiro, M. F., Filomatori, C. V. & Gamarnik, A. V. Structural and functional studies of the promoter element for dengue virus RNA replication. J. Virol. 83, 993\u20131008 (2009).","journal-title":"J. Virol."},{"key":"650_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0042-6822(78)90185-X","volume":"89","author":"G Wengler","year":"1978","unstructured":"Wengler, G., Wengler, G. & Gross, H. J. Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses. Virology 89, 423\u2013437 (1978).","journal-title":"Virology"},{"key":"650_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.virol.2007.12.035","volume":"374","author":"L Yu","year":"2008","unstructured":"Yu, L., Nomaguchi, M., Padmanabhan, R. & Markoff, L. Specific requirements for elements of the 5\u2019 and 3\u2019 terminal regions in flavivirus RNA synthesis and viral replication. Virology 374, 170\u2013185 (2008).","journal-title":"Virology"},{"key":"650_CR30","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1101\/gad.1444206","volume":"20","author":"CV Filomatori","year":"2006","unstructured":"Filomatori, C. V. et al. A 5\u2019 RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev. 20, 2238\u20132249 (2006).","journal-title":"Genes Dev."},{"key":"650_CR31","doi-asserted-by":"publisher","first-page":"a011544","DOI":"10.1101\/cshperspect.a011544","volume":"4","author":"AG Hinnebusch","year":"2012","unstructured":"Hinnebusch, A. G. & Lorsch, J. R. The mechanism of eukaryotic translation initiation: new insights and challenges. Cold Spring Harb. Perspect. Biol. 4, a011544 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"650_CR32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1261\/rna.2309906","volume":"12","author":"JR Babendure","year":"2006","unstructured":"Babendure, J. R., Babendure, J. L., Ding, J. H. & Tsien, R. Y. Control of mammalian translation by mRNA structure near caps. RNA 12, 851\u2013861 (2006).","journal-title":"RNA"},{"key":"650_CR33","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/art.22497","volume":"56","author":"SV Kozyrev","year":"2007","unstructured":"Kozyrev, S. V. et al. Structural insertion\/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum. 56, 1234\u20131241 (2007).","journal-title":"Arthritis Rheum."},{"key":"650_CR34","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1093\/nar\/gkt347","volume":"41","author":"K Endo","year":"2013","unstructured":"Endo, K., Stapleton, J. A., Hayashi, K., Saito, H. & Inoue, T. Quantitative and simultaneous translational control of distinct mammalian mRNAs. Nucleic Acids Res. 41, e135 (2013).","journal-title":"Nucleic Acids Res."},{"key":"650_CR35","doi-asserted-by":"publisher","first-page":"e0183974","DOI":"10.1371\/journal.pone.0183974","volume":"12","author":"F Huang","year":"2017","unstructured":"Huang, F., Spangler, J. R. & Huang, A. Y. In vivo cloning of up to 16 kb plasmids in E. coli is as simple as PCR. PLoS ONE 12, e0183974 (2017).","journal-title":"PLoS ONE"},{"key":"650_CR36","first-page":"242","volume":"67","author":"MP Bradley","year":"2017","unstructured":"Bradley, M. P. & Nagamine, C. M. Animal models of Zika virus. Comp. Med. 67, 242\u2013252 (2017).","journal-title":"Comp. Med."},{"key":"650_CR37","doi-asserted-by":"publisher","first-page":"107608","DOI":"10.1016\/j.biotechadv.2020.107608","volume":"44","author":"S Kiesslich","year":"2020","unstructured":"Kiesslich, S. & Kamen, A. A. Vero cell upstream bioprocess development for the production of viral vectors and vaccines. Biotechnol. Adv. 44, 107608 (2020).","journal-title":"Biotechnol. Adv."},{"key":"650_CR38","doi-asserted-by":"publisher","first-page":"e0005608","DOI":"10.1371\/journal.pntd.0005608","volume":"11","author":"H Boigard","year":"2017","unstructured":"Boigard, H. et al. Zika virus-like particle (VLP) based vaccine. PLoS Negl. Trop. Dis. 11, e0005608 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"650_CR39","doi-asserted-by":"publisher","first-page":"e0004139","DOI":"10.1371\/journal.pntd.0004139","volume":"9","author":"D Acharya","year":"2015","unstructured":"Acharya, D., Paul, A. M., Anderson, J. F., Huang, F. & Bai, F. Loss of glycosaminoglycan receptor binding after mosquito cell passage reduces Chikungunya virus infectivity. PLoS Negl. Trop. Dis. 9, e0004139 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"650_CR40","doi-asserted-by":"publisher","first-page":"e01529","DOI":"10.1128\/JVI.01529-16","volume":"91","author":"D Acharya","year":"2017","unstructured":"Acharya, D. et al. Interleukin-17A promotes CD8+ T cell cytotoxicity to facilitate West Nile virus clearance. J. Virol. 91, e01529\u201316 (2017).","journal-title":"J. Virol."},{"key":"650_CR41","doi-asserted-by":"publisher","first-page":"e1000610","DOI":"10.1371\/journal.ppat.1000610","volume":"5","author":"F Bai","year":"2009","unstructured":"Bai, F. et al. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog. 5, e1000610 (2009).","journal-title":"PLoS Pathog."},{"key":"650_CR42","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.immuni.2008.11.012","volume":"30","author":"T Town","year":"2009","unstructured":"Town, T. et al. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 30, 242\u2013253 (2009).","journal-title":"Immunity"},{"key":"650_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763\u2013767 (2017).","journal-title":"Nat. Med."},{"key":"650_CR44","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"P Abbink","year":"2016","unstructured":"Abbink, P. et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353, 1129\u20131132 (2016).","journal-title":"Science"},{"key":"650_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep46375","volume":"7","author":"K Sumathy","year":"2017","unstructured":"Sumathy, K. et al. Protective efficacy of Zika vaccine in AG129 mouse model. Sci. Rep. 7, 46375 (2017).","journal-title":"Sci. Rep."},{"key":"650_CR46","doi-asserted-by":"publisher","first-page":"e01722","DOI":"10.1128\/JVI.01722-17","volume":"92","author":"K Xu","year":"2018","unstructured":"Xu, K. et al. Recombinant chimpanzee adenovirus vaccine AdC7-M\/E protects against Zika virus infection and testis damage. J. Virol. 92, e01722\u201317 (2018).","journal-title":"J. Virol."},{"key":"650_CR47","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1056\/NEJMoa1708120","volume":"385","author":"P Tebas","year":"2017","unstructured":"Tebas, P. et al. Safety and immunogenicity of an anti-Zika virus DNA vaccine\u2014preliminary report. N. Engl. J. Med. 385, e35 (2017).","journal-title":"N. Engl. J. Med."},{"key":"650_CR48","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Rapid development of a DNA vaccine for Zika virus. Science 354, 237\u2013240 (2016).","journal-title":"Science"},{"key":"650_CR49","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114\u20131125 e1110 (2017).","journal-title":"Cell"},{"key":"650_CR50","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/pbi.12796","volume":"16","author":"M Yang","year":"2018","unstructured":"Yang, M., Sun, H., Lai, H., Hurtado, J. & Chen, Q. Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice. Plant Biotechnol. J. 16, 572\u2013580 (2018).","journal-title":"Plant Biotechnol. J."},{"key":"650_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02975-w","volume":"9","author":"XF Li","year":"2018","unstructured":"Li, X. F. et al. Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone. Nat. Commun. 9, 673 (2018).","journal-title":"Nat. Commun."},{"key":"650_CR52","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1016\/j.mayocp.2019.05.016","volume":"94","author":"GA Poland","year":"2019","unstructured":"Poland, G. A., Ovsyannikova, I. G. & Kennedy, R. B. Zika vaccine development: current status. Mayo Clin. Proc. 94, 2572\u20132586 (2019).","journal-title":"Mayo Clin. Proc."},{"key":"650_CR53","doi-asserted-by":"publisher","first-page":"583077","DOI":"10.3389\/fimmu.2020.583077","volume":"11","author":"M Brisse","year":"2020","unstructured":"Brisse, M., Vrba, S. M., Kirk, N., Liang, Y. & Ly, H. Emerging concepts and technologies in vaccine development. Front. Immunol. 11, 583077 (2020).","journal-title":"Front. Immunol."},{"key":"650_CR54","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.clinthera.2017.07.001","volume":"39","author":"MH Collins","year":"2017","unstructured":"Collins, M. H. & Metz, S. W. Progress and works in progress: update on flavivirus vaccine development. Clin. Ther. 39, 1519\u20131536 (2017).","journal-title":"Clin. Ther."},{"key":"650_CR55","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","volume":"80","author":"J Lee","year":"2018","unstructured":"Lee, J., Arun Kumar, S., Jhan, Y. Y. & Bishop, C. J. Engineering DNA vaccines against infectious diseases. Acta Biomater. 80, 31\u201347 (2018).","journal-title":"Acta Biomater."},{"key":"650_CR56","doi-asserted-by":"publisher","first-page":"718753","DOI":"10.3389\/fbioe.2021.718753","volume":"9","author":"T Liu","year":"2021","unstructured":"Liu, T., Liang, Y. & Huang, L. Development and delivery systems of mRNA vaccines. Front. Bioeng. Biotechnol. 9, 718753 (2021).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"650_CR57","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.vaccine.2007.11.082","volume":"26","author":"JE Blaney Jr.","year":"2008","unstructured":"Blaney, J. E. Jr. et al. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3\u2019 untranslated region (3\u2019-UTR) or by exchange of the DENV-3 3\u2019-UTR with that of DENV-4. Vaccine 26, 817\u2013828 (2008).","journal-title":"Vaccine"},{"key":"650_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00737-8","volume":"8","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat. Commun. 8, 676 (2017).","journal-title":"Nat. Commun."},{"key":"650_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.virol.2005.08.043","volume":"345","author":"MP Ramanathan","year":"2006","unstructured":"Ramanathan, M. P. et al. Host cell killing by the West Nile virus NS2B\u2013NS3 proteolytic complex: NS3 alone is sufficient to recruit caspase-8-based apoptotic pathway. Virology 345, 56\u201372 (2006).","journal-title":"Virology"},{"key":"650_CR60","doi-asserted-by":"publisher","first-page":"197793","DOI":"10.1016\/j.virusres.2019.197793","volume":"275","author":"H Xing","year":"2020","unstructured":"Xing, H. et al. Zika NS2B is a crucial factor recruiting NS3 to the ER and activating its protease activity. Virus Res. 275, 197793 (2020).","journal-title":"Virus Res."},{"key":"650_CR61","doi-asserted-by":"publisher","first-page":"e1006164","DOI":"10.1371\/journal.ppat.1006164","volume":"13","author":"JR Bowen","year":"2017","unstructured":"Bowen, J. R. et al. Zika virus antagonizes type I interferon responses during infection of human dendritic cells. PLoS Pathog. 13, e1006164 (2017).","journal-title":"PLoS Pathog."},{"key":"650_CR62","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","volume":"19","author":"A Grant","year":"2016","unstructured":"Grant, A. et al. Zika virus targets human STAT2 to inhibit type I interferon signaling. Cell Host Microbe 19, 882\u2013890 (2016).","journal-title":"Cell Host Microbe"},{"key":"650_CR63","doi-asserted-by":"publisher","first-page":"e0130121","DOI":"10.1128\/JVI.01301-21","volume":"96","author":"JP Parisien","year":"2022","unstructured":"Parisien, J. P., Lenoir, J. J., Alvarado, G. & Horvath, C. M. The human STAT2 coiled-coil domain contains a degron for Zika virus interferon evasion. J. Virol. 96, e0130121 (2022).","journal-title":"J. Virol."},{"key":"650_CR64","doi-asserted-by":"publisher","first-page":"109107","DOI":"10.1016\/j.celrep.2021.109107","volume":"35","author":"F Gambino Jr.","year":"2021","unstructured":"Gambino, F. Jr. et al. A vaccine inducing solely cytotoxic T lymphocytes fully prevents Zika virus infection and fetal damage. Cell Rep. 35, 109107 (2021).","journal-title":"Cell Rep."},{"key":"650_CR65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ebiom.2017.02.003","volume":"17","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. A cDNA clone-launched platform for high-yield production of inactivated Zika vaccine. EBioMedicine 17, 145\u2013156 (2017).","journal-title":"EBioMedicine"},{"key":"650_CR66","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","volume":"19","author":"C Shan","year":"2016","unstructured":"Shan, C. et al. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19, 891\u2013900 (2016).","journal-title":"Cell Host Microbe"},{"key":"650_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/srep32227","volume":"6","author":"D Acharya","year":"2016","unstructured":"Acharya, D. et al. An ultrasensitive electrogenerated chemiluminescence-based immunoassay for specific detection of Zika virus. Sci. Rep. 6, 32227 (2016).","journal-title":"Sci. Rep."},{"key":"650_CR68","doi-asserted-by":"publisher","first-page":"588382","DOI":"10.3389\/fimmu.2020.588382","volume":"11","author":"B Neupane","year":"2020","unstructured":"Neupane, B. et al. Interleukin-17A facilitates Chikungunya virus infection by inhibiting IFN-alpha2 expression. Front. Immunol. 11, 588382 (2020).","journal-title":"Front. Immunol."},{"key":"650_CR69","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1086\/428507","volume":"191","author":"F Bai","year":"2005","unstructured":"Bai, F. et al. Use of RNA interference to prevent lethal murine West Nile virus infection. J. Infect. Dis. 191, 1148\u20131154 (2005).","journal-title":"J. Infect. Dis."},{"key":"650_CR70","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1099\/vir.0.066084-0","volume":"95","author":"AM Paul","year":"2014","unstructured":"Paul, A. M. et al. Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro. J. Gen. Virol. 95, 1712\u20131722 (2014).","journal-title":"J. Gen. Virol."},{"key":"650_CR71","doi-asserted-by":"publisher","first-page":"e7729","DOI":"10.7717\/peerj.7729","volume":"7","author":"M Cacciabue","year":"2019","unstructured":"Cacciabue, M., Curr\u00e1, A. & Gismondi, M. I. ViralPlaque: a Fiji macro for automated assessment of viral plaque statistics. PeerJ 7, e7729 (2019).","journal-title":"PeerJ"},{"key":"650_CR72","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/vaccines11020197","volume":"11","author":"H Sun","year":"2023","unstructured":"Sun, H. et al. Antibody-dependent enhancement activity of a plant-made vaccine against West Nile virus. Vaccines 11, 197 (2023).","journal-title":"Vaccines"},{"key":"650_CR73","doi-asserted-by":"publisher","first-page":"e6136","DOI":"10.7717\/peerj.6136","volume":"6","author":"RJ Andrews","year":"2018","unstructured":"Andrews, R. J., Roche, J. & Moss, W. N. ScanFold: an approach for genome-wide discovery of local RNA structural elements-applications to Zika virus and HIV. PeerJ 6, e6136 (2018).","journal-title":"PeerJ"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00650-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00650-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00650-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T01:56:56Z","timestamp":1680487016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00650-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00650-w","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}